United States · FDA National Drug Code directory
Fenofibric Acid
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-245_4f5277a1-2983-4cf9-b589-714d5fc586c0
- Product NDC
- 46708-245
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- Fenofibric Acid
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170518
- Source listing expiry
- 20261231
Source-listed ingredients
- FENOFIBRIC ACID — 135 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (46708-245-30) · 46708-245-30
- 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (46708-245-90) · 46708-245-90
- 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (46708-245-91) · 46708-245-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →